Clinical Trials Browser

Phase 2 × Terminated × Interferons × Clear all

NCT00678288 2014-12-11

A Study to Assess Sorafenib Alone and in Combination With Low-Dose Interferon Following Unsuccessful Treatment With Sunitinib in Patients With Advanced Renal Cell Cancer.

Phase 2 Terminated

16 enrolled 6 charts

Carcinoma, Renal Cell